| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2024 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 03 | 5 | CDC | 3/25/2025 | $0 |
| | 2025 | 2023 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 4 | CDC | 10/8/2024 | $0 |
| | 2025 | 2023 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 4 | CDC | 10/8/2024 | $0 |
| | 2025 | 2023 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 4 | CDC | 10/8/2024 | $0 |
| | 2025 | 2023 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 4 | CDC | 10/8/2024 | $0 |
| | 2025 | 2023 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 02 | 5 | CDC | 3/25/2025 | $0 |
| | 2025 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 4 | CDC | 10/8/2024 | $0 |
| | 2025 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 5 | CDC | 3/24/2025 | $0 |
| | 2025 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 4 | CDC | 10/8/2024 | $0 |
| | 2025 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 4 | CDC | 10/8/2024 | $0 |
| | 2025 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 4 | CDC | 10/8/2024 | $0 |
| | 2025 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 4 | CDC | 10/8/2024 | $0 |
| | 2025 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 4 | CDC | 10/8/2024 | $0 |
| | 2025 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 4 | CDC | 10/8/2024 | $0 |
| | 2025 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 4 | CDC | 10/8/2024 | $0 |
| | 2025 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 4 | CDC | 10/8/2024 | $0 |
| | 2025 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 4 | CDC | 10/8/2024 | $0 |
| | 2025 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 4 | CDC | 10/8/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $400,000 ) |
| | 2024 | 2024 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 5 | CDC | 7/31/2024 | $125,000 |
| | 2024 | 2024 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 5 | CDC | 7/31/2024 | $275,000 |
| | 2024 | 2023 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 5 | CDC | 7/31/2024 | $0 |
| | 2024 | 2023 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 5 | CDC | 7/31/2024 | $0 |
| | 2024 | 2023 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 5 | CDC | 7/31/2024 | $0 |
| | 2024 | 2023 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 5 | CDC | 7/31/2024 | $0 |
| | 2024 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 5 | CDC | 7/31/2024 | $0 |
| | 2024 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 5 | CDC | 7/31/2024 | $0 |
| | 2024 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 5 | CDC | 7/31/2024 | $0 |
| | 2024 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 5 | CDC | 7/31/2024 | $0 |
| | 2024 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 5 | CDC | 7/31/2024 | $0 |
| | 2024 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 5 | CDC | 7/31/2024 | $0 |
| | 2024 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 5 | CDC | 7/31/2024 | $0 |
| | 2024 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 5 | CDC | 7/31/2024 | $0 |
| | 2024 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 5 | CDC | 7/31/2024 | $0 |
| | 2024 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 5 | CDC | 7/31/2024 | $0 |
| | 2024 | 2021 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 5 | CDC | 7/31/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,100,000 ) (Continued on the next page) |
| | 2023 | 2023 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $650,000 |
| | 2023 | 2023 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $50,000 |
| | 2023 | 2023 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $50,000 |
| | 2023 | 2023 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $350,000 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 3 | CDC | 11/29/2022 | -$193,311 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 3 | CDC | 11/29/2022 | $0 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 3 | CDC | 11/29/2022 | $0 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $0 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 3 | CDC | 11/29/2022 | $0 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $0 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 01 | 3 | CDC | 11/29/2022 | $0 |
| | 2023 | 2022 | INFECTIOUS DISEASES SOCIETY OF AMERICA | 4040 WILSON BLVD | ARLINGTON | VA | 22203-4439 | ARLINGTON | USA | NU50CK000574 | Optimizing COVID-19 Infection Prevention & Control in Clinical Practice | 00 | 4 | CDC | 8/31/2023 | $0 |
|
